Articles By Anuja Singh
Will CMS’s 2026 WISeR AI Pilot Shift Traditional Medicare’s Access—How Might Algorithmic Prior Authorizations…
Key Highlights: AI-Powered Prior Authorization: New Model and ScopeCMS’s WISeR (Wasteful and Inappropriate Service Reduction) program introduces AI…
By
Can Harvard’s FaceAge and Emerging AI Facial Recognition Apps Revolutionize Disease Prediction and Personalized…
Key Highlights: AI Facial Recognition as a Medical BiomarkerDeveloped at Harvard Medical School, the FaceAge algorithm analyzes photos…
How Will BioNTech’s Patent Settlement Impact the Future of mRNA COVID-19 and Influenza Vaccines…
Key Highlights Resolving Patent Litigation and Securing LicensesBioNTech SE and Pfizer reached agreements with CureVac N.V. and GlaxoSmithKline…
Could Eli Lilly’s AI-Driven Innovation Accelerate Biopharma Growth to $62 Billion in 2025?
Key Highlights Robust Revenue Growth Powered by AI-Driven ProductsIn Q2 2025, Eli Lilly delivered impressive top-line performance with…
Could Chai’s $70 Million OpenAI-Backed Funding Propel the Next Leap in AI-Engineered Drug Discovery Success?
Key Highlights Breakthrough Funding and Industry BackingThe Series A round brings Chai Discovery’s total capital to $100 million,…
Is Illinois’ Ban on AI in Mental Healthcare a Turning Point for Human-Centered Therapy Regulation in the U.S.?
Key Highlights Background and Impetus for the BanDriven by incidents where AI chatbots posed risks—including cases suggesting harmful…
Will CMS’s 2026 WISeR AI Pilot Shift Traditional Medicare’s Access—How Might Algorithmic Prior Authorizations…
Key Highlights: AI-Powered Prior Authorization: New Model and ScopeCMS’s WISeR (Wasteful and Inappropriate Service Reduction) program introduces AI…
Can Harvard’s FaceAge and Emerging AI Facial Recognition Apps Revolutionize Disease Prediction and Personalized…
Key Highlights: AI Facial Recognition as a Medical BiomarkerDeveloped at Harvard Medical School, the FaceAge algorithm analyzes photos…
How Will BioNTech’s Patent Settlement Impact the Future of mRNA COVID-19 and Influenza Vaccines…
Key Highlights Resolving Patent Litigation and Securing LicensesBioNTech SE and Pfizer reached agreements with CureVac N.V. and GlaxoSmithKline…
Could Eli Lilly’s AI-Driven Innovation Accelerate Biopharma Growth to $62 Billion in 2025?
Key Highlights Robust Revenue Growth Powered by AI-Driven ProductsIn Q2 2025, Eli Lilly delivered impressive top-line performance with…
Could Chai’s $70 Million OpenAI-Backed Funding Propel the Next Leap in AI-Engineered Drug Discovery Success?
Key Highlights Breakthrough Funding and Industry BackingThe Series A round brings Chai Discovery’s total capital to $100 million,…
Is Illinois’ Ban on AI in Mental Healthcare a Turning Point for Human-Centered Therapy Regulation in the U.S.?
Key Highlights Background and Impetus for the BanDriven by incidents where AI chatbots posed risks—including cases suggesting harmful…